These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 35060066)

  • 1. Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease.
    Morinaga M; Kon K; Uchiyama A; Fukada H; Fukuhara K; Yaginuma R; Nakadera E; Yamashina S; Ikejima K
    Hepatol Int; 2022 Apr; 16(2):348-358. PubMed ID: 35060066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.
    Staufer K; Huber-Schönauer U; Strebinger G; Pimingstorfer P; Suesse S; Scherzer TM; Paulweber B; Ferenci P; Stimpfl T; Yegles M; Datz C; Trauner M
    J Hepatol; 2022 Oct; 77(4):918-930. PubMed ID: 35605744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease.
    Díaz LA; Arab JP; Louvet A; Bataller R; Arrese M
    Nat Rev Gastroenterol Hepatol; 2023 Dec; 20(12):764-783. PubMed ID: 37582985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians.
    Haren MT; Li M; Petkov J; McDermott RA
    BMC Public Health; 2010 Aug; 10():454. PubMed ID: 20682033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrowing the Patient-Physician Gap Based on Self-Reporting and Monthly Hepatologist Feedback for Patients With Alcohol-Related Liver Disease: Interventional Pilot Study Using a Journaling Smartphone App.
    Yamashiki N; Kawabata K; Murata M; Ikeda S; Fujimaki T; Suwa K; Seki T; Aramaki E; Naganuma M
    JMIR Form Res; 2023 Dec; 7():e44762. PubMed ID: 38113066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease.
    Hernandez-Tejero M; Clemente-Sanchez A; Bataller R
    J Clin Exp Hepatol; 2023; 13(1):75-87. PubMed ID: 36647416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Alcohol Use Disorder in Patients With Alcoholic Liver Disease.
    Murthy P; Shadakshari D; Mahadevan J; Chand PK
    J Clin Exp Hepatol; 2022; 12(6):1514-1526. PubMed ID: 36340303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.
    Hagström H; Hegmar H; Moreno C
    United European Gastroenterol J; 2024 Mar; 12(2):168-176. PubMed ID: 38381115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of fatty liver index as a predictor of hepatic steatosis in Asian populations: Impact of alcohol consumption and sex.
    Nomura T; Ono M; Kobayashi K; Akaiwa Y; Ayaki M; Ogi T; Ogi M; Takahashi H; Ishikawa K; Morishita A; Kobara H; Masaki T
    Hepatol Res; 2023 Oct; 53(10):968-977. PubMed ID: 37300349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between the Level of Alcohol Consumption and Abnormality in Biomarkers According to Facial Flushing in Korean Male Drinkers.
    Kim SG; Kim JS; Kim SS; Jung JG; Yun SJ; Kim EC
    Korean J Fam Med; 2013 Mar; 34(2):123-30. PubMed ID: 23560211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of alcohol use, consumption of micronutrient and macronutrients, and liver health in the 2017-2018 National Health and Nutrition Examination Survey.
    Warner JB; Zirnheld KH; Hu H; Floyd A; Kong M; McClain CJ; Kirpich IA
    Alcohol Clin Exp Res; 2022 Nov; 46(11):2025-2040. PubMed ID: 36124871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysis.
    Mori K; Akiyama Y; Tanaka M; Sato T; Endo K; Hosaka I; Hanawa N; Sakamoto N; Furuhashi M
    J Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38629681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive risk markers in alcoholism.
    Niemelä O
    Adv Clin Chem; 2023; 116():113-181. PubMed ID: 37852718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers for alcohol consumption.
    Das SK; Nayak P; Vasudevan DM
    Indian J Clin Biochem; 2003 Jul; 18(2):111-8. PubMed ID: 23105401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of IgA Autoantibody Generation, Inflammatory Responses and Extracellular Matrix Metabolism in Patients with Alcohol Use Disorder.
    Niemelä O; Bloigu A; Bloigu R; Nivukoski U; Kultti J; Pohjasniemi H
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ratio of miR-122 to miR-20a (miR-122/miR-20a) Is a Useful Minimally Invasive Biomarker for Non-Alcoholic Fatty Liver Disease Detection.
    Hattori Y; Yamada H; Munetsuna E; Fujii R; Ando Y; Yamazaki M; Mizuno G; Tsuboi Y; Ishihara Y; Ichino N; Sugimoto K; Osakabe K; Ishikawa H; Ohashi K; Suzuki K
    Genet Test Mol Biomarkers; 2023 Aug; 27(8):239-247. PubMed ID: 37643325
    [No Abstract]   [Full Text] [Related]  

  • 17. Drinking and laboratory biomarkers, and nutritional status characterize the clinical presentation of early-stage alcohol-associated liver disease.
    Vatsalya V; Royer AJ; Jha SK; Parthasarathy R; Tiwari H; Feng W; Ramchandani VA; Kirpich IA; McClain CJ
    Adv Clin Chem; 2023; 114():83-108. PubMed ID: 37268335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA1c of 5.8% or higher as the most useful indicator for recommendation of ultrasonography to detect nonalcoholic fatty liver disease.
    Tatsuta M; Ono M; Kimura S; Zuigyo K; Sato Y; Tomida A; Kobayashi M; Yoshikawa R; Murao S; Tani J; Morishita A; Kobara H; Himoto T; Maeta T; Mori Y; Kohi F; Masaki T
    JGH Open; 2023 Dec; 7(12):990-997. PubMed ID: 38162856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
    Staufer K; Stauber RE
    Biomedicines; 2023 Jul; 11(8):. PubMed ID: 37626604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical diagnosis of alcoholism.
    Das SK; Vasudevan DM
    Indian J Clin Biochem; 2005 Jan; 20(1):35-42. PubMed ID: 23105491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.